SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950144-00-001339
Filing Date
2000-02-04
Accepted
2000-02-04 00:00:00
Documents
1
Group Members
AIM MANAGEMENT GROUP INC.AMVESCAP GROUP SERVICES, INC.AMVESCAP PLCAMVESCAP PLC \GA\AVZ, INC.INVESCO (NY) ASSET MANAGEMENT, INC.INVESCO CAPITAL MANAGEMENT, INC.INVESCO FUNDS GROUP, INC.INVESCO MANAGEMENT & RESEARCH, INC.INVESCO NORTH AMERICAN HOLDINGS, INC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A 32064
  Complete submission text file 0000950144-00-001339.txt   34660
Mailing Address 1315 PEACHTREE ST NE C/O INVESCO ALTANTA GA 30309
Business Address 11 DEVONSHIRE SQUARE LONDON EC2M 4YR X0 011447162634
AMVESCAP PLC \GA\ (Filed by) CIK: 0000864047 (see all company filings)

IRS No.: 630780404 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 0000

Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45671 | Film No.: 523230
SIC: 2833 Medicinal Chemicals & Botanical Products